Circulating Tumor DNA Alterations in Advanced Urothelial Carcinoma and Association With Clinical Outcomes: A Pilot Study

European urology oncology - Netherlands
doi 10.1016/j.euo.2019.02.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Circulating Tumor DNA as a Marker of Therapeutic Response in Patients With Renal Cell Carcinoma: A Pilot Study

Clinical Genitourinary Cancer
OncologyUrology
2016English

Clinical Application of Circulating Tumor DNA in the Genetic Analysis of Patients With Advanced GIST

Molecular Cancer Therapeutics
Cancer ResearchOncology
2017English

P2.01-106 a Comparative Analysis of Genomic Alterations by Tumor Tissue and Circulating Tumor DNA in Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Cabozantinib in Combination With Immunotherapy for Advanced Renal Cell Carcinoma and Urothelial Carcinoma: Rationale and Clinical Evidence

Molecular Cancer Therapeutics
Cancer ResearchOncology
2019English

Advanced Urothelial Carcinoma: Next-Generation Sequencing Reveals Diverse Genomic Alterations and Targets of Therapy

Modern Pathology
Forensic MedicinePathology
2013English

Clinical Factors Associated With Circulating Tumor DNA (ctDNA) in Primary Breast Cancer

Molecular Oncology
Cancer ResearchMedicineOncologyGeneticsMolecular Medicine
2019English

Histone Deacetylase Inhibition Has Targeted Clinical Benefit in ARID1A Mutated Advanced Urothelial Carcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Clinical Utility of Circulating Cell-Free DNA in Advanced Colorectal Cancer

PLoS ONE
Multidisciplinary
2017English

Unique Association Between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy